Is MSH2 a breast cancer susceptibility gene?
- 139 Downloads
Mutations in the DNA mismatch repair gene MSH2 lead to increased replication error and microsatellite instability and account for a substantial proportion of hereditary non-polyposis colorectal cancer (Lynch syndrome). A recent international collaborative genome-wide linkage scan (GWS) for breast cancer susceptibility loci found some evidence for there being a breast cancer susceptibility gene in a genomic region on chromosome 2p close to MSH2. We sought to investigate the possibility that mutations in MSH2 might explain the multiple cases of breast cancer in some families that were included in the international GWS. DNA samples from the affected probands of 59 multiple-case breast cancer families, many of whom gave LOD scores >0.5 in the MSH2 region, were screened for large genomic alterations in MSH2 via the Multiplex Ligation-dependant Probe Amplification (MLPA) assay and for coding region mutations via exonic sequencing. Several of the families also contained cases of colorectal cancer in addition to breast cancer and had been included in the GWS that had identified a positive LOD score on chromosome 2p. Using MLPA, c.1236C > T was identified in one proband but this variant was not predicted to create an alternate acceptor/donor site within exon 7 MSH2 using in silico analyses. A c.1734T > C was identified in a second proband via exonic sequencing but testing of the variant in other family members did not support segregation of this variant with disease. Extensive screening of 59 multiple-case breast cancer families did not identify any coding region mutations or larger genomic alterations in MSH2 that might implicate MSH2 as a breast cancer susceptibility gene.
KeywordsFamilial breast cancer Breast cancer susceptibility genes Linkage studies Candidate susceptibility genes MSH2
- 6.Muller A, Edmonston TB, Corao DA et al (2002) Exclusion of breast cancer as an integral tumour of hereditary nonpolyposi colorectal cancer. Cancer Res 62:1012–1019Google Scholar
- 7.de Leeuw WJ, Puijenbroek M, Tollenaar RAEM et al (2003) Correspondence re Muller et al. exclusion of breast cancer as an integral tumour of hereditary nonpolyposi colorectal cancer. Cancer Res 63:1148–1149Google Scholar
- 10.http://www.kconfab.org. Accessed Sept 2007
- 11.Hopper JL, Chenevix-Trench G, Jolley DJ et al (1999) Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). J Natl Cancer Inst Monogr 26:95–100PubMedGoogle Scholar
- 14.Dite GS, Jenkins MA, Hocking JS et al (2002) Strong familial risks associated with early-onset breast cancer are only partially BRCA1- or BRCA2-related. JNCI 19:95,448–457, 2003Google Scholar
- 15.Chenevix-Trench G, Spurdle AB, Gatei M et al (2002) Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst 94, 205–215. Erratum in: J Natl Cancer Inst 2002 94, 952Google Scholar
- 17.Mann GJ, Thorne H, Belleine RL et al (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8(1):R12. Epub 2006 Feb 13Google Scholar
- 21.http://www.violin.genet.sickkids.on.ca/∼ali/splicesitefinder.html. Accessed Sept 2006